Cargando…
The Efficacy and Safety of Etripamil Nasal Spray for Acute Paroxysmal Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Paroxysmal supraventricular tachycardia (PSVT) treatment requires medically supervised intervention. Etripamil is a novel short-acting calcium channel blocker. Its intranasal spray formulation has a rapid onset of action and shows promise for the unsupervised treatment of PSVT. OBJECTIVE...
Autores principales: | Abuelazm, Mohamed, Kambalapalli, Soumya, Saleh, Othman, Elzeftawy, Mohamed A., Albakri, Khaled, Gowaily, Ibrahim, Abdelazeem, Basel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328856/ https://www.ncbi.nlm.nih.gov/pubmed/37351813 http://dx.doi.org/10.1007/s40256-023-00592-7 |
Ejemplares similares
-
Etripamil: Self-management of supraventricular tachycardia is not far away?
por: Faisaluddin, Mohammed, et al.
Publicado: (2019) -
First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)
por: Stambler, Bruce S., et al.
Publicado: (2022) -
Paroxysmal Supraventricular Tachycardia
por: Arnold, Casey, et al.
Publicado: (2019) -
Malignant Paroxysmal Supraventricular Tachycardia
por: Anguera, I, et al.
Publicado: (2010) -
Cisplatin induced paroxysmal supraventricular tachycardia
por: Raja, Waseem, et al.
Publicado: (2013)